NCT00059943View on ClinicalTrials.gov

Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2005

Conditions
Breast CancerLung CancerProstate Cancer
Interventions
DRUG

docetaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00059943 - Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | Biotech Hunter | Biotech Hunter